AAP
Ardsley Advisory Partners’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-701,500
| Closed | -$5.86M | – | 134 |
|
|
2023
Q3 | $5.86M | Sell |
701,500
-204,500
| -23% | -$1.71M | 1.31% | 19 |
|
|
2023
Q2 | $12M | Hold |
906,000
| – | – | 2.04% | 8 |
|
|
2023
Q1 | $10.5M | Buy |
906,000
+1,000
| +0.1% | +$11.6K | 2.3% | 11 |
|
|
2022
Q4 | $7.4M | Buy |
+905,000
| New | +$7.4M | 1.53% | 23 |
|
|
2016
Q4 | – | Sell |
-15,000
| Closed | -$134K | – | 155 |
|
|
2016
Q3 | $134K | Hold |
15,000
| – | – | 0.02% | 130 |
|
|
2016
Q2 | $106K | Buy |
15,000
+5,000
| +50% | +$35.3K | 0.02% | 133 |
|
|
2016
Q1 | $85K | Buy |
+10,000
| New | +$85K | 0.01% | 125 |
|